AKT1 and central nervous system cancer: Its anticancer effects have been observed in many types of cancer, including: leukemias, cervical cancer, gliomas, and liver cancer, and this activity is associated with downregulation of the PI3k-Akt/PKB pathway (SGC-7901 gastric cancer cells) [15,16,17].